Global Pruritus Therapeutics Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
Summary
Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.
In this report, we study the drugs for pruritus.
According to APO Research, The global Pruritus Therapeutics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Pruritus Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Pruritus Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Pruritus Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Pruritus Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Pruritus Therapeutics include J&J, Abbott, Amgen, LEO Pharma, Novartis, Bayer, Pfizer, UCB Pharma and GlaxoSmithKline, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Pruritus Therapeutics, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pruritus Therapeutics, also provides the value of main regions and countries. Of the upcoming market potential for Pruritus Therapeutics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pruritus Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Pruritus Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Pruritus Therapeutics company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Pruritus Therapeutics segment by Company
1. To analyze and research the global Pruritus Therapeutics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Pruritus Therapeutics key companies, revenue, market share, and recent developments.
3. To split the Pruritus Therapeutics breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Pruritus Therapeutics market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Pruritus Therapeutics significant trends, drivers, influence factors in global and regions.
6. To analyze Pruritus Therapeutics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pruritus Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pruritus Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pruritus Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pruritus Therapeutics industry.
Chapter 3: Detailed analysis of Pruritus Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Pruritus Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Pruritus Therapeutics in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.
In this report, we study the drugs for pruritus.
According to APO Research, The global Pruritus Therapeutics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Pruritus Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Pruritus Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Pruritus Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Pruritus Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Pruritus Therapeutics include J&J, Abbott, Amgen, LEO Pharma, Novartis, Bayer, Pfizer, UCB Pharma and GlaxoSmithKline, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Pruritus Therapeutics, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pruritus Therapeutics, also provides the value of main regions and countries. Of the upcoming market potential for Pruritus Therapeutics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pruritus Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Pruritus Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Pruritus Therapeutics company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Pruritus Therapeutics segment by Company
- J&J
- Abbott
- Amgen
- LEO Pharma
- Novartis
- Bayer
- Pfizer
- UCB Pharma
- GlaxoSmithKline
- Galderma
- Huapont
- Antihistamines
- Corticosteroids
- Calcineurin Inhibitors
- Others
- External Use
- Oral
- Injection
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global Pruritus Therapeutics status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Pruritus Therapeutics key companies, revenue, market share, and recent developments.
3. To split the Pruritus Therapeutics breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Pruritus Therapeutics market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Pruritus Therapeutics significant trends, drivers, influence factors in global and regions.
6. To analyze Pruritus Therapeutics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pruritus Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pruritus Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pruritus Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pruritus Therapeutics industry.
Chapter 3: Detailed analysis of Pruritus Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Pruritus Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Pruritus Therapeutics in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Pruritus Therapeutics Market Size, 2019 VS 2023 VS 2030
1.3 Global Pruritus Therapeutics Market Size (2019-2030)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 PRURITUS THERAPEUTICS MARKET DYNAMICS
2.1 Pruritus Therapeutics Industry Trends
2.2 Pruritus Therapeutics Industry Drivers
2.3 Pruritus Therapeutics Industry Opportunities and Challenges
2.4 Pruritus Therapeutics Industry Restraints
3 PRURITUS THERAPEUTICS MARKET BY COMPANY
3.1 Global Pruritus Therapeutics Company Revenue Ranking in 2023
3.2 Global Pruritus Therapeutics Revenue by Company (2019-2024)
3.3 Global Pruritus Therapeutics Company Ranking, 2022 VS 2023 VS 2024
3.4 Global Pruritus Therapeutics Company Manufacturing Base & Headquarters
3.5 Global Pruritus Therapeutics Company, Product Type & Application
3.6 Global Pruritus Therapeutics Company Commercialization Time
3.7 Market Competitive Analysis
3.7.1 Global Pruritus Therapeutics Market CR5 and HHI
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.7.3 2023 Pruritus Therapeutics Tier 1, Tier 2, and Tier
3.8 Mergers & Acquisitions, Expansion
4 PRURITUS THERAPEUTICS MARKET BY TYPE
4.1 Pruritus Therapeutics Type Introduction
4.1.1 Antihistamines
4.1.2 Corticosteroids
4.1.3 Calcineurin Inhibitors
4.1.4 Others
4.2 Global Pruritus Therapeutics Sales Value by Type
4.2.1 Global Pruritus Therapeutics Sales Value by Type (2019 VS 2023 VS 2030)
4.2.2 Global Pruritus Therapeutics Sales Value by Type (2019-2030)
4.2.3 Global Pruritus Therapeutics Sales Value Share by Type (2019-2030)
5 PRURITUS THERAPEUTICS MARKET BY APPLICATION
5.1 Pruritus Therapeutics Application Introduction
5.1.1 External Use
5.1.2 Oral
5.1.3 Injection
5.2 Global Pruritus Therapeutics Sales Value by Application
5.2.1 Global Pruritus Therapeutics Sales Value by Application (2019 VS 2023 VS 2030)
5.2.2 Global Pruritus Therapeutics Sales Value by Application (2019-2030)
5.2.3 Global Pruritus Therapeutics Sales Value Share by Application (2019-2030)
6 PRURITUS THERAPEUTICS MARKET BY REGION
6.1 Global Pruritus Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030
6.2 Global Pruritus Therapeutics Sales Value by Region (2019-2030)
6.2.1 Global Pruritus Therapeutics Sales Value by Region: 2019-2024
6.2.2 Global Pruritus Therapeutics Sales Value by Region (2025-2030)
6.3 North America
6.3.1 North America Pruritus Therapeutics Sales Value (2019-2030)
6.3.2 North America Pruritus Therapeutics Sales Value Share by Country, 2023 VS 2030
6.4 Europe
6.4.1 Europe Pruritus Therapeutics Sales Value (2019-2030)
6.4.2 Europe Pruritus Therapeutics Sales Value Share by Country, 2023 VS 2030
6.5 Asia-Pacific
6.5.1 Asia-Pacific Pruritus Therapeutics Sales Value (2019-2030)
6.5.2 Asia-Pacific Pruritus Therapeutics Sales Value Share by Country, 2023 VS 2030
6.6 Latin America
6.6.1 Latin America Pruritus Therapeutics Sales Value (2019-2030)
6.6.2 Latin America Pruritus Therapeutics Sales Value Share by Country, 2023 VS 2030
6.7 Middle East & Africa
6.7.1 Middle East & Africa Pruritus Therapeutics Sales Value (2019-2030)
6.7.2 Middle East & Africa Pruritus Therapeutics Sales Value Share by Country, 2023 VS 2030
7 PRURITUS THERAPEUTICS MARKET BY COUNTRY
7.1 Global Pruritus Therapeutics Sales Value by Country: 2019 VS 2023 VS 2030
7.2 Global Pruritus Therapeutics Sales Value by Country (2019-2030)
7.2.1 Global Pruritus Therapeutics Sales Value by Country (2019-2024)
7.2.2 Global Pruritus Therapeutics Sales Value by Country (2025-2030)
7.3 USA
7.3.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.3.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.3.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.4 Canada
7.4.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.4.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.4.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.5 Germany
7.5.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.5.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.6 France
7.6.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.6.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.7 U.K.
7.7.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.7.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.8 Italy
7.8.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.8.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.9 Netherlands
7.9.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.9.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.10 Nordic Countries
7.10.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.10.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.11 China
7.11.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.11.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.12 Japan
7.12.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.12.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.13 South Korea
7.13.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.13.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.14 Southeast Asia
7.14.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.14.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.15 India
7.15.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.15.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.16 Australia
7.16.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.16.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.17 Mexico
7.17.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.17.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.18 Brazil
7.18.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.18.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.19 Turkey
7.19.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.19.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.20 Saudi Arabia
7.20.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.20.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.21 UAE
7.21.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.21.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 J&J
8.1.1 J&J Comapny Information
8.1.2 J&J Business Overview
8.1.3 J&J Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
8.1.4 J&J Pruritus Therapeutics Product Portfolio
8.1.5 J&J Recent Developments
8.2 Abbott
8.2.1 Abbott Comapny Information
8.2.2 Abbott Business Overview
8.2.3 Abbott Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
8.2.4 Abbott Pruritus Therapeutics Product Portfolio
8.2.5 Abbott Recent Developments
8.3 Amgen
8.3.1 Amgen Comapny Information
8.3.2 Amgen Business Overview
8.3.3 Amgen Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
8.3.4 Amgen Pruritus Therapeutics Product Portfolio
8.3.5 Amgen Recent Developments
8.4 LEO Pharma
8.4.1 LEO Pharma Comapny Information
8.4.2 LEO Pharma Business Overview
8.4.3 LEO Pharma Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
8.4.4 LEO Pharma Pruritus Therapeutics Product Portfolio
8.4.5 LEO Pharma Recent Developments
8.5 Novartis
8.5.1 Novartis Comapny Information
8.5.2 Novartis Business Overview
8.5.3 Novartis Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
8.5.4 Novartis Pruritus Therapeutics Product Portfolio
8.5.5 Novartis Recent Developments
8.6 Bayer
8.6.1 Bayer Comapny Information
8.6.2 Bayer Business Overview
8.6.3 Bayer Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
8.6.4 Bayer Pruritus Therapeutics Product Portfolio
8.6.5 Bayer Recent Developments
8.7 Pfizer
8.7.1 Pfizer Comapny Information
8.7.2 Pfizer Business Overview
8.7.3 Pfizer Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
8.7.4 Pfizer Pruritus Therapeutics Product Portfolio
8.7.5 Pfizer Recent Developments
8.8 UCB Pharma
8.8.1 UCB Pharma Comapny Information
8.8.2 UCB Pharma Business Overview
8.8.3 UCB Pharma Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
8.8.4 UCB Pharma Pruritus Therapeutics Product Portfolio
8.8.5 UCB Pharma Recent Developments
8.9 GlaxoSmithKline
8.9.1 GlaxoSmithKline Comapny Information
8.9.2 GlaxoSmithKline Business Overview
8.9.3 GlaxoSmithKline Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
8.9.4 GlaxoSmithKline Pruritus Therapeutics Product Portfolio
8.9.5 GlaxoSmithKline Recent Developments
8.10 Galderma
8.10.1 Galderma Comapny Information
8.10.2 Galderma Business Overview
8.10.3 Galderma Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
8.10.4 Galderma Pruritus Therapeutics Product Portfolio
8.10.5 Galderma Recent Developments
8.11 Huapont
8.11.1 Huapont Comapny Information
8.11.2 Huapont Business Overview
8.11.3 Huapont Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
8.11.4 Huapont Pruritus Therapeutics Product Portfolio
8.11.5 Huapont Recent Developments
9 CONCLUDING INSIGHTS
10 APPENDIX
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
1.1 Product Definition
1.2 Global Pruritus Therapeutics Market Size, 2019 VS 2023 VS 2030
1.3 Global Pruritus Therapeutics Market Size (2019-2030)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 PRURITUS THERAPEUTICS MARKET DYNAMICS
2.1 Pruritus Therapeutics Industry Trends
2.2 Pruritus Therapeutics Industry Drivers
2.3 Pruritus Therapeutics Industry Opportunities and Challenges
2.4 Pruritus Therapeutics Industry Restraints
3 PRURITUS THERAPEUTICS MARKET BY COMPANY
3.1 Global Pruritus Therapeutics Company Revenue Ranking in 2023
3.2 Global Pruritus Therapeutics Revenue by Company (2019-2024)
3.3 Global Pruritus Therapeutics Company Ranking, 2022 VS 2023 VS 2024
3.4 Global Pruritus Therapeutics Company Manufacturing Base & Headquarters
3.5 Global Pruritus Therapeutics Company, Product Type & Application
3.6 Global Pruritus Therapeutics Company Commercialization Time
3.7 Market Competitive Analysis
3.7.1 Global Pruritus Therapeutics Market CR5 and HHI
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.7.3 2023 Pruritus Therapeutics Tier 1, Tier 2, and Tier
3.8 Mergers & Acquisitions, Expansion
4 PRURITUS THERAPEUTICS MARKET BY TYPE
4.1 Pruritus Therapeutics Type Introduction
4.1.1 Antihistamines
4.1.2 Corticosteroids
4.1.3 Calcineurin Inhibitors
4.1.4 Others
4.2 Global Pruritus Therapeutics Sales Value by Type
4.2.1 Global Pruritus Therapeutics Sales Value by Type (2019 VS 2023 VS 2030)
4.2.2 Global Pruritus Therapeutics Sales Value by Type (2019-2030)
4.2.3 Global Pruritus Therapeutics Sales Value Share by Type (2019-2030)
5 PRURITUS THERAPEUTICS MARKET BY APPLICATION
5.1 Pruritus Therapeutics Application Introduction
5.1.1 External Use
5.1.2 Oral
5.1.3 Injection
5.2 Global Pruritus Therapeutics Sales Value by Application
5.2.1 Global Pruritus Therapeutics Sales Value by Application (2019 VS 2023 VS 2030)
5.2.2 Global Pruritus Therapeutics Sales Value by Application (2019-2030)
5.2.3 Global Pruritus Therapeutics Sales Value Share by Application (2019-2030)
6 PRURITUS THERAPEUTICS MARKET BY REGION
6.1 Global Pruritus Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030
6.2 Global Pruritus Therapeutics Sales Value by Region (2019-2030)
6.2.1 Global Pruritus Therapeutics Sales Value by Region: 2019-2024
6.2.2 Global Pruritus Therapeutics Sales Value by Region (2025-2030)
6.3 North America
6.3.1 North America Pruritus Therapeutics Sales Value (2019-2030)
6.3.2 North America Pruritus Therapeutics Sales Value Share by Country, 2023 VS 2030
6.4 Europe
6.4.1 Europe Pruritus Therapeutics Sales Value (2019-2030)
6.4.2 Europe Pruritus Therapeutics Sales Value Share by Country, 2023 VS 2030
6.5 Asia-Pacific
6.5.1 Asia-Pacific Pruritus Therapeutics Sales Value (2019-2030)
6.5.2 Asia-Pacific Pruritus Therapeutics Sales Value Share by Country, 2023 VS 2030
6.6 Latin America
6.6.1 Latin America Pruritus Therapeutics Sales Value (2019-2030)
6.6.2 Latin America Pruritus Therapeutics Sales Value Share by Country, 2023 VS 2030
6.7 Middle East & Africa
6.7.1 Middle East & Africa Pruritus Therapeutics Sales Value (2019-2030)
6.7.2 Middle East & Africa Pruritus Therapeutics Sales Value Share by Country, 2023 VS 2030
7 PRURITUS THERAPEUTICS MARKET BY COUNTRY
7.1 Global Pruritus Therapeutics Sales Value by Country: 2019 VS 2023 VS 2030
7.2 Global Pruritus Therapeutics Sales Value by Country (2019-2030)
7.2.1 Global Pruritus Therapeutics Sales Value by Country (2019-2024)
7.2.2 Global Pruritus Therapeutics Sales Value by Country (2025-2030)
7.3 USA
7.3.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.3.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.3.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.4 Canada
7.4.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.4.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.4.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.5 Germany
7.5.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.5.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.6 France
7.6.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.6.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.7 U.K.
7.7.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.7.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.8 Italy
7.8.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.8.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.9 Netherlands
7.9.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.9.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.10 Nordic Countries
7.10.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.10.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.11 China
7.11.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.11.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.12 Japan
7.12.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.12.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.13 South Korea
7.13.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.13.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.14 Southeast Asia
7.14.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.14.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.15 India
7.15.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.15.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.16 Australia
7.16.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.16.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.17 Mexico
7.17.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.17.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.18 Brazil
7.18.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.18.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.19 Turkey
7.19.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.19.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.20 Saudi Arabia
7.20.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.20.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
7.21 UAE
7.21.1 Global Pruritus Therapeutics Sales Value Growth Rate (2019-2030)
7.21.2 Global Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 J&J
8.1.1 J&J Comapny Information
8.1.2 J&J Business Overview
8.1.3 J&J Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
8.1.4 J&J Pruritus Therapeutics Product Portfolio
8.1.5 J&J Recent Developments
8.2 Abbott
8.2.1 Abbott Comapny Information
8.2.2 Abbott Business Overview
8.2.3 Abbott Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
8.2.4 Abbott Pruritus Therapeutics Product Portfolio
8.2.5 Abbott Recent Developments
8.3 Amgen
8.3.1 Amgen Comapny Information
8.3.2 Amgen Business Overview
8.3.3 Amgen Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
8.3.4 Amgen Pruritus Therapeutics Product Portfolio
8.3.5 Amgen Recent Developments
8.4 LEO Pharma
8.4.1 LEO Pharma Comapny Information
8.4.2 LEO Pharma Business Overview
8.4.3 LEO Pharma Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
8.4.4 LEO Pharma Pruritus Therapeutics Product Portfolio
8.4.5 LEO Pharma Recent Developments
8.5 Novartis
8.5.1 Novartis Comapny Information
8.5.2 Novartis Business Overview
8.5.3 Novartis Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
8.5.4 Novartis Pruritus Therapeutics Product Portfolio
8.5.5 Novartis Recent Developments
8.6 Bayer
8.6.1 Bayer Comapny Information
8.6.2 Bayer Business Overview
8.6.3 Bayer Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
8.6.4 Bayer Pruritus Therapeutics Product Portfolio
8.6.5 Bayer Recent Developments
8.7 Pfizer
8.7.1 Pfizer Comapny Information
8.7.2 Pfizer Business Overview
8.7.3 Pfizer Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
8.7.4 Pfizer Pruritus Therapeutics Product Portfolio
8.7.5 Pfizer Recent Developments
8.8 UCB Pharma
8.8.1 UCB Pharma Comapny Information
8.8.2 UCB Pharma Business Overview
8.8.3 UCB Pharma Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
8.8.4 UCB Pharma Pruritus Therapeutics Product Portfolio
8.8.5 UCB Pharma Recent Developments
8.9 GlaxoSmithKline
8.9.1 GlaxoSmithKline Comapny Information
8.9.2 GlaxoSmithKline Business Overview
8.9.3 GlaxoSmithKline Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
8.9.4 GlaxoSmithKline Pruritus Therapeutics Product Portfolio
8.9.5 GlaxoSmithKline Recent Developments
8.10 Galderma
8.10.1 Galderma Comapny Information
8.10.2 Galderma Business Overview
8.10.3 Galderma Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
8.10.4 Galderma Pruritus Therapeutics Product Portfolio
8.10.5 Galderma Recent Developments
8.11 Huapont
8.11.1 Huapont Comapny Information
8.11.2 Huapont Business Overview
8.11.3 Huapont Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
8.11.4 Huapont Pruritus Therapeutics Product Portfolio
8.11.5 Huapont Recent Developments
9 CONCLUDING INSIGHTS
10 APPENDIX
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
LIST OF TABLES
Table 1. Pruritus Therapeutics Industry Trends
Table 2. Pruritus Therapeutics Industry Drivers
Table 3. Pruritus Therapeutics Industry Opportunities and Challenges
Table 4. Pruritus Therapeutics Industry Restraints
Table 5. Global Pruritus Therapeutics Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Pruritus Therapeutics Revenue Share by Company (2019-2024)
Table 7. Global Pruritus Therapeutics Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 8. Global Pruritus Therapeutics Key Company Manufacturing Base & Headquarters
Table 9. Global Pruritus Therapeutics Company, Product Type & Application
Table 10. Global Pruritus Therapeutics Company Commercialization Time
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Pruritus Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Major Companies of Antihistamines
Table 15. Major Companies of Corticosteroids
Table 16. Major Companies of Calcineurin Inhibitors
Table 17. Major Companies of Others
Table 18. Global Pruritus Therapeutics Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Pruritus Therapeutics Sales Value by Type (2019-2024) & (US$ Million)
Table 20. Global Pruritus Therapeutics Sales Value by Type (2025-2030) & (US$ Million)
Table 21. Global Pruritus Therapeutics Sales Value Share by Type (2019-2024)
Table 22. Global Pruritus Therapeutics Sales Value Share by Type (2025-2030)
Table 23. Major Companies of External Use
Table 24. Major Companies of Oral
Table 25. Major Companies of Injection
Table 26. Global Pruritus Therapeutics Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 27. Global Pruritus Therapeutics Sales Value by Application (2019-2024) & (US$ Million)
Table 28. Global Pruritus Therapeutics Sales Value by Application (2025-2030) & (US$ Million)
Table 29. Global Pruritus Therapeutics Sales Value Share by Application (2019-2024)
Table 30. Global Pruritus Therapeutics Sales Value Share by Application (2025-2030)
Table 31. Global Pruritus Therapeutics Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 32. Global Pruritus Therapeutics Sales Value by Region (2019-2024) & (US$ Million)
Table 33. Global Pruritus Therapeutics Sales Value Share by Region (2019-2024)
Table 34. Global Pruritus Therapeutics Sales Value by Region (2025-2030) & (US$ Million)
Table 35. Global Pruritus Therapeutics Sales Value Share by Region (2025-2030)
Table 36. Global Pruritus Therapeutics Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 37. Global Pruritus Therapeutics Sales Value by Country (2019-2024) & (US$ Million)
Table 38. Global Pruritus Therapeutics Sales Value Market Share by Country (2019-2024)
Table 39. Global Pruritus Therapeutics Sales Value by Country (2025-2030) & (US$ Million)
Table 40. Global Pruritus Therapeutics Sales Value Market Share by Country (2025-2030)
Table 41. J&J Company Information
Table 42. J&J Business Overview
Table 43. J&J Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 44. J&J Pruritus Therapeutics Product Portfolio
Table 45. J&J Recent Development
Table 46. Abbott Company Information
Table 47. Abbott Business Overview
Table 48. Abbott Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 49. Abbott Pruritus Therapeutics Product Portfolio
Table 50. Abbott Recent Development
Table 51. Amgen Company Information
Table 52. Amgen Business Overview
Table 53. Amgen Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 54. Amgen Pruritus Therapeutics Product Portfolio
Table 55. Amgen Recent Development
Table 56. LEO Pharma Company Information
Table 57. LEO Pharma Business Overview
Table 58. LEO Pharma Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 59. LEO Pharma Pruritus Therapeutics Product Portfolio
Table 60. LEO Pharma Recent Development
Table 61. Novartis Company Information
Table 62. Novartis Business Overview
Table 63. Novartis Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 64. Novartis Pruritus Therapeutics Product Portfolio
Table 65. Novartis Recent Development
Table 66. Bayer Company Information
Table 67. Bayer Business Overview
Table 68. Bayer Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 69. Bayer Pruritus Therapeutics Product Portfolio
Table 70. Bayer Recent Development
Table 71. Pfizer Company Information
Table 72. Pfizer Business Overview
Table 73. Pfizer Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 74. Pfizer Pruritus Therapeutics Product Portfolio
Table 75. Pfizer Recent Development
Table 76. UCB Pharma Company Information
Table 77. UCB Pharma Business Overview
Table 78. UCB Pharma Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 79. UCB Pharma Pruritus Therapeutics Product Portfolio
Table 80. UCB Pharma Recent Development
Table 81. GlaxoSmithKline Company Information
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 84. GlaxoSmithKline Pruritus Therapeutics Product Portfolio
Table 85. GlaxoSmithKline Recent Development
Table 86. Galderma Company Information
Table 87. Galderma Business Overview
Table 88. Galderma Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 89. Galderma Pruritus Therapeutics Product Portfolio
Table 90. Galderma Recent Development
Table 91. Huapont Company Information
Table 92. Huapont Business Overview
Table 93. Huapont Pruritus Therapeutics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Huapont Pruritus Therapeutics Product Portfolio
Table 95. Huapont Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Authors List of This Report
Table 98. Secondary Sources
Table 99. Primary Sources
Table 1. Pruritus Therapeutics Industry Trends
Table 2. Pruritus Therapeutics Industry Drivers
Table 3. Pruritus Therapeutics Industry Opportunities and Challenges
Table 4. Pruritus Therapeutics Industry Restraints
Table 5. Global Pruritus Therapeutics Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Pruritus Therapeutics Revenue Share by Company (2019-2024)
Table 7. Global Pruritus Therapeutics Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 8. Global Pruritus Therapeutics Key Company Manufacturing Base & Headquarters
Table 9. Global Pruritus Therapeutics Company, Product Type & Application
Table 10. Global Pruritus Therapeutics Company Commercialization Time
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Pruritus Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Major Companies of Antihistamines
Table 15. Major Companies of Corticosteroids
Table 16. Major Companies of Calcineurin Inhibitors
Table 17. Major Companies of Others
Table 18. Global Pruritus Therapeutics Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Pruritus Therapeutics Sales Value by Type (2019-2024) & (US$ Million)
Table 20. Global Pruritus Therapeutics Sales Value by Type (2025-2030) & (US$ Million)
Table 21. Global Pruritus Therapeutics Sales Value Share by Type (2019-2024)
Table 22. Global Pruritus Therapeutics Sales Value Share by Type (2025-2030)
Table 23. Major Companies of External Use
Table 24. Major Companies of Oral
Table 25. Major Companies of Injection
Table 26. Global Pruritus Therapeutics Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 27. Global Pruritus Therapeutics Sales Value by Application (2019-2024) & (US$ Million)
Table 28. Global Pruritus Therapeutics Sales Value by Application (2025-2030) & (US$ Million)
Table 29. Global Pruritus Therapeutics Sales Value Share by Application (2019-2024)
Table 30. Global Pruritus Therapeutics Sales Value Share by Application (2025-2030)
Table 31. Global Pruritus Therapeutics Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 32. Global Pruritus Therapeutics Sales Value by Region (2019-2024) & (US$ Million)
Table 33. Global Pruritus Therapeutics Sales Value Share by Region (2019-2024)
Table 34. Global Pruritus Therapeutics Sales Value by Region (2025-2030) & (US$ Million)
Table 35. Global Pruritus Therapeutics Sales Value Share by Region (2025-2030)
Table 36. Global Pruritus Therapeutics Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 37. Global Pruritus Therapeutics Sales Value by Country (2019-2024) & (US$ Million)
Table 38. Global Pruritus Therapeutics Sales Value Market Share by Country (2019-2024)
Table 39. Global Pruritus Therapeutics Sales Value by Country (2025-2030) & (US$ Million)
Table 40. Global Pruritus Therapeutics Sales Value Market Share by Country (2025-2030)
Table 41. J&J Company Information
Table 42. J&J Business Overview
Table 43. J&J Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 44. J&J Pruritus Therapeutics Product Portfolio
Table 45. J&J Recent Development
Table 46. Abbott Company Information
Table 47. Abbott Business Overview
Table 48. Abbott Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 49. Abbott Pruritus Therapeutics Product Portfolio
Table 50. Abbott Recent Development
Table 51. Amgen Company Information
Table 52. Amgen Business Overview
Table 53. Amgen Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 54. Amgen Pruritus Therapeutics Product Portfolio
Table 55. Amgen Recent Development
Table 56. LEO Pharma Company Information
Table 57. LEO Pharma Business Overview
Table 58. LEO Pharma Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 59. LEO Pharma Pruritus Therapeutics Product Portfolio
Table 60. LEO Pharma Recent Development
Table 61. Novartis Company Information
Table 62. Novartis Business Overview
Table 63. Novartis Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 64. Novartis Pruritus Therapeutics Product Portfolio
Table 65. Novartis Recent Development
Table 66. Bayer Company Information
Table 67. Bayer Business Overview
Table 68. Bayer Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 69. Bayer Pruritus Therapeutics Product Portfolio
Table 70. Bayer Recent Development
Table 71. Pfizer Company Information
Table 72. Pfizer Business Overview
Table 73. Pfizer Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 74. Pfizer Pruritus Therapeutics Product Portfolio
Table 75. Pfizer Recent Development
Table 76. UCB Pharma Company Information
Table 77. UCB Pharma Business Overview
Table 78. UCB Pharma Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 79. UCB Pharma Pruritus Therapeutics Product Portfolio
Table 80. UCB Pharma Recent Development
Table 81. GlaxoSmithKline Company Information
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 84. GlaxoSmithKline Pruritus Therapeutics Product Portfolio
Table 85. GlaxoSmithKline Recent Development
Table 86. Galderma Company Information
Table 87. Galderma Business Overview
Table 88. Galderma Pruritus Therapeutics Revenue (US$ Million) and Gross Margin (2019-2024)
Table 89. Galderma Pruritus Therapeutics Product Portfolio
Table 90. Galderma Recent Development
Table 91. Huapont Company Information
Table 92. Huapont Business Overview
Table 93. Huapont Pruritus Therapeutics Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Huapont Pruritus Therapeutics Product Portfolio
Table 95. Huapont Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Authors List of This Report
Table 98. Secondary Sources
Table 99. Primary Sources
LIST OF FIGURES
Figure 1. Pruritus Therapeutics Product Picture
Figure 2. Global Pruritus Therapeutics Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Pruritus Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 4. Global Pruritus Therapeutics Company Revenue Ranking in 2023 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 7. Antihistamines Picture
Figure 8. Corticosteroids Picture
Figure 9. Calcineurin Inhibitors Picture
Figure 10. Others Picture
Figure 11. Global Pruritus Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Pruritus Therapeutics Sales Value Share 2019 VS 2023 VS 2030
Figure 13. Global Pruritus Therapeutics Sales Value Share by Type (2019-2030)
Figure 14. External Use Picture
Figure 15. Oral Picture
Figure 16. Injection Picture
Figure 17. Global Pruritus Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Pruritus Therapeutics Sales Value Share 2019 VS 2023 VS 2030
Figure 19. Global Pruritus Therapeutics Sales Value Share by Application (2019-2030)
Figure 20. Global Pruritus Therapeutics Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 21. Global Pruritus Therapeutics Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 22. North America Pruritus Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 23. North America Pruritus Therapeutics Sales Value Share by Country (%), 2023 VS 2030
Figure 24. Europe Pruritus Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 25. Europe Pruritus Therapeutics Sales Value Share by Country (%), 2023 VS 2030
Figure 26. Asia-Pacific Pruritus Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 27. Asia-Pacific Pruritus Therapeutics Sales Value Share by Country (%), 2023 VS 2030
Figure 28. Latin America Pruritus Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 29. Latin America Pruritus Therapeutics Sales Value Share by Country (%), 2023 VS 2030
Figure 30. Middle East & Africa Pruritus Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 31. Middle East & Africa Pruritus Therapeutics Sales Value Share by Country (%), 2023 VS 2030
Figure 32. USA Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 33. USA Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 34. USA Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 35. Canada Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 36. Canada Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 37. Canada Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 38. Germany Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 39. Germany Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 40. Germany Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 41. France Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 42. France Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 43. France Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 44. U.K. Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 45. U.K. Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 46. U.K. Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 47. Italy Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 48. Italy Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 49. Italy Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 50. Netherlands Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 51. Netherlands Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 52. Netherlands Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 53. Nordic Countries Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 54. Nordic Countries Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 55. Nordic Countries Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 56. China Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 57. China Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 58. China Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 59. Japan Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 60. Japan Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 61. Japan Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 62. South Korea Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 63. South Korea Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 64. South Korea Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 65. Southeast Asia Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 66. Southeast Asia Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 67. Southeast Asia Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 68. India Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 69. India Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 70. India Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 71. Australia Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 72. Australia Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 73. Australia Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 74. Mexico Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 75. Mexico Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 76. Mexico Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 77. Brazil Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 78. Brazil Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 79. Brazil Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 80. Turkey Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 81. Turkey Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 82. Turkey Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 83. Saudi Arabia Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 84. Saudi Arabia Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 85. Saudi Arabia Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 86. UAE Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 87. UAE Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 88. UAE Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 89. Years Considered
Figure 90. Research Process
Figure 91. Key Executives Interviewed
Figure 1. Pruritus Therapeutics Product Picture
Figure 2. Global Pruritus Therapeutics Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Pruritus Therapeutics Market Size (2019-2030) & (US$ Million)
Figure 4. Global Pruritus Therapeutics Company Revenue Ranking in 2023 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 7. Antihistamines Picture
Figure 8. Corticosteroids Picture
Figure 9. Calcineurin Inhibitors Picture
Figure 10. Others Picture
Figure 11. Global Pruritus Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Pruritus Therapeutics Sales Value Share 2019 VS 2023 VS 2030
Figure 13. Global Pruritus Therapeutics Sales Value Share by Type (2019-2030)
Figure 14. External Use Picture
Figure 15. Oral Picture
Figure 16. Injection Picture
Figure 17. Global Pruritus Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Pruritus Therapeutics Sales Value Share 2019 VS 2023 VS 2030
Figure 19. Global Pruritus Therapeutics Sales Value Share by Application (2019-2030)
Figure 20. Global Pruritus Therapeutics Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 21. Global Pruritus Therapeutics Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 22. North America Pruritus Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 23. North America Pruritus Therapeutics Sales Value Share by Country (%), 2023 VS 2030
Figure 24. Europe Pruritus Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 25. Europe Pruritus Therapeutics Sales Value Share by Country (%), 2023 VS 2030
Figure 26. Asia-Pacific Pruritus Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 27. Asia-Pacific Pruritus Therapeutics Sales Value Share by Country (%), 2023 VS 2030
Figure 28. Latin America Pruritus Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 29. Latin America Pruritus Therapeutics Sales Value Share by Country (%), 2023 VS 2030
Figure 30. Middle East & Africa Pruritus Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 31. Middle East & Africa Pruritus Therapeutics Sales Value Share by Country (%), 2023 VS 2030
Figure 32. USA Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 33. USA Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 34. USA Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 35. Canada Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 36. Canada Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 37. Canada Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 38. Germany Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 39. Germany Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 40. Germany Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 41. France Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 42. France Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 43. France Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 44. U.K. Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 45. U.K. Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 46. U.K. Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 47. Italy Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 48. Italy Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 49. Italy Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 50. Netherlands Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 51. Netherlands Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 52. Netherlands Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 53. Nordic Countries Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 54. Nordic Countries Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 55. Nordic Countries Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 56. China Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 57. China Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 58. China Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 59. Japan Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 60. Japan Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 61. Japan Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 62. South Korea Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 63. South Korea Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 64. South Korea Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 65. Southeast Asia Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 66. Southeast Asia Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 67. Southeast Asia Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 68. India Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 69. India Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 70. India Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 71. Australia Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 72. Australia Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 73. Australia Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 74. Mexico Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 75. Mexico Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 76. Mexico Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 77. Brazil Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 78. Brazil Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 79. Brazil Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 80. Turkey Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 81. Turkey Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 82. Turkey Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 83. Saudi Arabia Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 84. Saudi Arabia Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 85. Saudi Arabia Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 86. UAE Pruritus Therapeutics Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 87. UAE Pruritus Therapeutics Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 88. UAE Pruritus Therapeutics Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 89. Years Considered
Figure 90. Research Process
Figure 91. Key Executives Interviewed
